Ypsomed Holding AG
SIX:YPSN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ypsomed Holding AG
SIX:YPSN
|
CH |
|
R
|
Royal Bank of Canada
BMV:RYN
|
CA |
|
K
|
Klaveness Combination Carriers ASA
OSE:KCC
|
NO |
|
C
|
Clean Harbors Inc
F:CH6
|
US |
|
F
|
Friwo AG
DUS:CEA
|
DE |
|
B
|
Baxter International Inc
F:BTL
|
US |
|
C
|
Capitol Federal Financial Inc
F:CFW
|
US |
|
Himax Technologies Inc
NASDAQ:HIMX
|
TW |
|
Acanthe Developpement SE
F:ADX
|
FR |
|
C
|
Cadiz Inc
F:2ZC
|
US |
|
Washington H. Soul Pattinson and Company Ltd
F:WD3
|
AU |
|
Innate Pharma SA
PAR:IPH
|
FR |
|
Grupo Mexico SAB de CV
F:4GE
|
MX |
Intrinsic Value
Is YPSN undervalued or overvalued?
See the intrinsic value estimate for Ypsomed Holding AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Ypsomed Does
Ypsomed Holding AG makes drug delivery devices that help patients inject medicines at home. Its core products include insulin pens, pen needles, autoinjectors, and pump systems for people who need regular injections, especially diabetes patients and other chronic-care users. The company also develops and sells connected devices and digital tools that help patients track treatment and use their medicines correctly.
- Headquarters
- Switzerland CH
- Employees
- 2 025
- IPO date
- Sep 22, 2004
Earnings Waterfall
Ypsomed Holding AG
The intrinsic value for Ypsomed Holding AG (YPSN) under the Base Case is hidden CHF.
Compared with the current market price of 397.2 CHF, the stock appears hidden.